Big or small, global or startup, the Navy Yard is a community of people and companies working alongside each other in an environment that is flexible, customizable, and often unconventional. These unique spaces come in varying heights, vintages, and floorplates; can accommodate business growth and expansion; and provide access to a large and talented regional workforce.

Congratulations to Coriell Life Sciences on earning their second Pharmacy Benefit Management Institute (PBMI) Excellence Award for Cost Containment om honor of their Corigen® Medication Safety Program, which eliminates a root cause of healthcare waste—medications that are harming people instead of helping them—and in turn reduces needless healthcare costs in a major way.

Sounds like a sci-fi movie right? But it’s not. Naval Surface Warfare Center, Philadelphia Division is testing laser-based sensors on robot dogs or drones as a way to perform battle damage assessment, repair, installation, and modernization – all remotely.

TOTE Services, LLC, (“TOTE Services”) an affiliate of TOTE, LLC (“TOTE Group”) and Philly Shipyard, Inc. (“Philly Shipyard”), the sole operating subsidiary of Philly Shipyard ASA (XOAX: PHLY) today marked a significant construction milestone at a keel laying ceremony for the second of five new purpose built, state-of-the-art training vessels for America’s state maritime academies. 

Naval Surface Warfare Center, Philadelphia Division employee Andrew C. Lucas was awarded the Armed Forces Civilian Service Medal (AFCSM) for participating on the Joint Assisted Acquisition (JA2) program that provided the acquisition and technical expertise needed to transition and accelerate the U.S. Government’s ongoing COVID-19 response and pandemic preparedness

Adaptimmune is building out its manufacturing space at the Navy Yard by almost 17k square feet. "This expansion will ensure we have the manufacturing capacity to meet the anticipated commercial demand for this product [afami-cel] as well as continued supply for our broad pipeline of additional clinical trials," said John Lunger, Adaptimmune’s chief patient supply officer.